In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current earnings expectations. But 24/7 Wall St. has one caveat.
courtesy of Sirius XM RadioHere is a look at the seven Nasdaq-traded stocks with the largest number of shares held short as of June 30. Six of the seven experienced declines in…
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.
A surge in short interest in Apple shares between the May 30 and June 13 settlement dates was enough to lift the tech giant into the top five most shorted stocks on…
bfishshadow via Wikimedia CommonsShort sellers continue to hold huge positions in the same handful of Nasdaq stocks, but among them, short interest in Sirius, the Nasdaq-traded stock with the largest short position,…
ThinkstockShort sellers have many reasons to bet against a stock, some of which are hedging or part of a larger theme. Other reasons may be a bet against a company or sector,…
A new research note from Credit Suisse maintains that the top large cap biotech leaders are leading the comeback rally from the hard sell-off. Here are the top large cap biotech stocks…
ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest health care…
bfishshadow via Wikimedia CommonsHere is a look at the seven Nasdaq-traded stocks with the largest number of shares held short as of May 15. Six of the seven experienced declines in short…
ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of the…
courtesy of Sirius XM RadioShort sellers continue to hold huge positions not only in troubled companies like BlackBerry Ltd. (NASDAQ: BBRY), but also in such tech giants as Intel. As of April…
In a new research report, the pharmaceutical and biotech analysts at RBC highlight their meetings with a group of six physicians. They favor four top stocks now as best positioned for continued…
bfishshadow via Wikimedia CommonsShort sellers continue to hold huge positions not only in troubled companies like BlackBerry and Staples, but also in blue chips like Microsoft. As of April 15, the most…
The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5. It jumped 23% over the next three weeks, and then gave it…
ThinkstockBy any stretch of normal measurement in earnings season, Gilead Sciences Inc. (NASDAQ: GILD) should have been a rocketing stock on Wednesday. Gilead blew away earnings and revenue estimates. Its Sovaldi Hepatitis…
